Showing results (451-460 of 498) with videos related to

Sort By:
Pageof 50
Neoplasia (New York, N.Y.)|September 6, 2007
Galectin-3 as a potential therapeutic target in tumors arising from malignant endotheliaKim D Johnson, Olga V Glinskii, Valeri V Mossine, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2017
Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed TherapyPeter L Anderson, Albert Y Liu, Jose R Castillo-Mancilla, et al.
The Journal of Antimicrobial Chemotherapy|May 17, 2019
Pharmacokinetics of tenofovir monoester and association with intracellular tenofovir diphosphate following single-dose tenofovir disoproxil fumarateKristina M Brooks, Mustafa E Ibrahim, Jose R Castillo-Mancilla, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2016
Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent DosingJose Castillo-Mancilla, Sharon Seifert, Kayla Campbell, et al.
Physical Review Letters|May 1, 2012
K→(ππ)(I=2) decay amplitude from lattice QCDT Blum, P A Boyle, N H Christ, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 29, 2019
Antiretroviral Therapy Adherence Interruptions Are Associated With Systemic Inflammation Among Ugandans Who Achieved Viral SuppressionNicholas Musinguzi, Jose Castillo-Mancilla, Mary Morrow, et al.
The Journal of Antimicrobial Chemotherapy|February 23, 2022
Predictors of 007 triphosphate concentrations in dried blood spots in persons with hepatitis C and active drug or alcohol useKristina M Brooks, Jose R Castillo-Mancilla, Mary Morrow, et al.
The Journal of Antimicrobial Chemotherapy|February 20, 2016
Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342)Jose R Castillo-Mancilla, Christina L Aquilante, Michael F Wempe, et al.
Pageof 50